Bolt Biotherapeutics is a biotechnology company that focuses on developing innovative immunotherapy treatments for cancer. The company utilizes its proprietary platform to create targeted therapies that engage the immune system to recognize and destroy cancerous cells more effectively. By harnessing the power of the body’s own immune response, Bolt aims to improve patient outcomes and provide new options for individuals battling various forms of cancer. Their research and development efforts are directed toward creating novel therapeutic candidates that can advance the field of cancer treatment.